21 – 30 of 47
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer
(
- Contribution to journal › Article
-
Mark
A systematic analysis of commonly used antibodies in cancer diagnostics
(
- Contribution to journal › Article
-
Mark
Investigation of molecular alterations of AKT-3 in triple-negative breast cancer
(
- Contribution to journal › Article
-
Mark
Peroxiredoxin-1 protects estrogen receptor alpha from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer
(
- Contribution to journal › Article
- 2013
-
Mark
Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer
(
- Contribution to journal › Article
-
Mark
Contribution of Antibody-based Protein Profiling to the Human Chromosome-centric Proteome Project (C-HPP)
(
- Contribution to journal › Article
-
Mark
CDK-mediated activation of the SCFFBXO28 ubiquitin ligase promotes MYC-driven transcription and tumourigenesis and predicts poor survival in breast cancer
(
- Contribution to journal › Article
- 2012
-
Mark
The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients
(
- Contribution to journal › Article
-
Mark
CD99 is a novel prognostic stromal marker in non-small cell lung cancer
(
- Contribution to journal › Article
- 2011
-
Mark
Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: An analysis of 215 cases from the Malmo Diet and Cancer Study
(
- Contribution to journal › Article